Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2020

Sep 4, 2020

30786_dirs_2020-09-04_e21a6a6f-2f80-4f2e-a230-10e97e5a6ce5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-09-02

Reporting Person: Last Andrew J. (EVP, Chief Operating Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-09-02 Restricted Stock Units $0 A 3610 Acquired Bio-Rad A Common Stock (3610) Direct
2020-09-02 Non-Qualified Stock Option (right to buy) $524.3 A 3610 Acquired 2030-09-02 Bio-Rad A Common Stock (3610) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock Direct

Footnotes

F1: Includes 23.3089 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2020.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.

F4: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.